Tao Capital
Asia, Beijing, China, Beijing'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Tao Capital is an investment firm.
Investor Profile
Tao Capital has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series A rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Health Care, Biopharma, Biotechnology.
Stage Focus
- Series C (43%)
- Series B (29%)
- Series A (14%)
- Seed (14%)
Country Focus
- China (57%)
- United States (43%)
Industry Focus
- Health Care
- Biopharma
- Biotechnology
- Medical
- Energy
- Energy Management
- Oil And Gas
- Oncology
- Therapeutics
- Cannabis
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
